Aimovig

Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig
Fierce Pharma
Amgen
Novartis
Aimovig
migraines
SEC
Flag link:
Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen
Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen
Fierce Pharma
Novartis
Amegen
Aimovig
migraines
Flag link:
Amgen and Novartis tap TV host to jump-start migraine conversations—and fuel understanding
Amgen and Novartis tap TV host to jump-start migraine conversations—and fuel understanding
Fierce Pharma
Aimovig
Amgen
Novartis
migraines
celebrity endorsements
Flag link:
Novartis’ Aimovig tops topiramate in migraine face-off
Novartis’ Aimovig tops topiramate in migraine face-off
Pharmaforum
Novartis
Aimovig
Topiramate
migraines
clinical trials
Flag link:
Amgen Highlights Long-Term Aimovig Data for Episodic Migraine
Amgen Highlights Long-Term Aimovig Data for Episodic Migraine
BioSpace
Amgen
Novartis
Aimovig
migraines
episodic migraines
Flag link:
Blow to Novartis as NICE rejects migraine drug Aimovig again
Blow to Novartis as NICE rejects migraine drug Aimovig again
Pharmaforum
Novartis
Aimovig
migraines
NICE
Flag link:
Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share
Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share
Fierce Pharma
Amgen
CGRPs
Aimovig
migraines
Eli Lilly
Emgality
Flag link:
Lilly's Emgality powers ahead with 'best-in-class' CGRP access
Lilly's Emgality powers ahead with 'best-in-class' CGRP access
Fierce Pharma
Eli Lilly
Emgality
migraines
Amgen
Aimovig
Teva Pharmaceutical
Ajovy
Flag link:
How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says
How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says
Fierce Pharma
Teva Pharmaceutical
migraines
Ajovy
Amgen
Eli Lilly
Emgality
Aimovig
neurologists
physicians
DTC advertising
Flag link:
Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions
Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions
Yahoo/Reuters
Eli Lilly
Amgen
Teva Pharmaceutical
migraines
Emgality
Aimovig
Flag link:
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
Xconomy
migraines
CGRP blockers
Aimovig
Amgen
Ajovy
Teva Pharmaceutical
Emgality
Eli Lilly
Flag link:
Scotland backs Aimovig for migraine after NICE says no
Scotland backs Aimovig for migraine after NICE says no
Pharmaforum
Scotland
NICE
migraines
Aimovig
Amgen
Novartis
Flag link:
Lawsuit over migraine deal could be good for Amgen, analysts say
Lawsuit over migraine deal could be good for Amgen, analysts say
Marketwatch
Novartis
Amgen
migraines
Aimovig
Flag link:
Amgen and Novartis file dueling lawsuits over their deal to market a migraine drug
Amgen and Novartis file dueling lawsuits over their deal to market a migraine drug
Stat
Novartis
Amgen
Aimovig
migraines
Flag link:
Novartis sues Amgen over migraine treatment Aimovig
Novartis sues Amgen over migraine treatment Aimovig
Yahoo/Reuters
Novartis
Amgen
Aimovig
migraines
Flag link:
CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
Reuters
CVS Health
migraines
Amgen
Teva Pharmaceutical
Eli Lilly
Aimovig
Ajovy
Emgality
Flag link:
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
Flag link:
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
NICE
UK
Amgen
Novartis
migraines
Aimovig
Flag link:
Amgen reckons with biosimilar and pricing pressures
Amgen reckons with biosimilar and pricing pressures
Biopharma Dive
Amgen
earnings
biosimilars
Aimovig
Flag link:
Being there: Amgen and Novartis roll out first ad campaign for migraine drug Aimovig
Being there: Amgen and Novartis roll out first ad campaign for migraine drug Aimovig
Fierce Pharma
Novartis
Amgen
Aimovig
DTC ads
television ads
Flag link:

Pages